Can neurofilament lightchain as endpoint in Phase 2 derisk clinical disability worsening in Phase 3 in multiple sclerosis?
| Autor: | Collignon, Olivier |
|---|---|
| Zdroj: | In Multiple Sclerosis and Related Disorders December 2023 80 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect